SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001764013-21-000098
Filing Date
2021-09-15
Accepted
2021-09-15 07:23:34
Documents
22
Period of Report
2021-09-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imvt-20210909.htm   iXBRL 8-K 62484
2 EX-10.1 exhibit101.htm EX-10.1 168099
3 EX-99.1 exhibit991-20210915.htm EX-99.1 11197
4 EX-99.2 exhibit992.htm EX-99.2 9065
8 GRAPHIC exhibit992001.jpg GRAPHIC 101798
9 GRAPHIC exhibit992002.jpg GRAPHIC 265706
10 GRAPHIC exhibit992003.jpg GRAPHIC 105990
11 GRAPHIC exhibit992004.jpg GRAPHIC 126726
12 GRAPHIC exhibit992005.jpg GRAPHIC 146629
13 GRAPHIC exhibit992006.jpg GRAPHIC 98746
14 GRAPHIC exhibit992007.jpg GRAPHIC 122551
  Complete submission text file 0001764013-21-000098.txt   1768199

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imvt-20210909.xsd EX-101.SCH 1908
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imvt-20210909_lab.xml EX-101.LAB 23970
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imvt-20210909_pre.xml EX-101.PRE 12642
15 EXTRACTED XBRL INSTANCE DOCUMENT imvt-20210909_htm.xml XML 10813
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-38906 | Film No.: 211254238
SIC: 2836 Biological Products, (No Diagnostic Substances)